Testimonials are one of the most powerful marketing tools in medicine. When a respected surgeon stands behind your device, when a patient shares their recovery story, when a hospital system endorses your technology -- those endorsements carry weight that no amount of corporate marketing can replicate. But in the medical device industry, testimonials exist at the intersection of FDA promotional regulations, FTC advertising guidelines, and common sense compliance -- and getting them wrong can cost you far more than the marketing value they provide.
I have been helping medical device companies navigate testimonial rules for 18 years, and I can tell you that this is one of the areas where companies most frequently stumble. The rules are not intuitive, the lines between compliant and non-compliant are blurry, and the consequences of crossing those lines are severe. In this article, I am going to give you a comprehensive guide to using testimonials in medical device marketing -- what you can do, what you cannot do, and how to build a testimonial program that drives sales without triggering regulatory action.
Why Testimonials Matter in Medical Device Marketing
Before we get into the rules, let us talk about why testimonials are so valuable -- and therefore so tempting for device companies to use aggressively.
Medical devices are evaluated and purchased by healthcare professionals who are, by training, skeptical of corporate marketing claims. They know that companies will present their products in the best possible light. But when a trusted colleague -- a fellow surgeon, a department chief, a respected researcher -- endorses a device, that recommendation carries credibility that corporate marketing cannot match.
Testimonials serve several critical marketing functions:
- Social proof: Demonstrating that respected professionals use and recommend your device
- Clinical credibility: Putting clinical claims in the context of real-world experience
- Emotional connection: Patient testimonials create emotional resonance that clinical data alone cannot achieve
- Competitive differentiation: KOL endorsements can be a significant competitive advantage
- Trust building: Third-party endorsements build trust faster than self-promotion
Because testimonials are so powerful, the FDA and FTC both regulate them closely. The FDA's framework for marketing compliance applies fully to testimonial content, and the FTC adds additional requirements around endorsements and disclosures.
The FDA's Framework for Testimonials
The FDA does not have a single guidance document titled "Testimonial Rules." Instead, testimonials are governed by the same promotional regulations that apply to all medical device marketing. Here is how the framework applies:
Testimonials as Promotional Labeling
When a medical device company uses a testimonial in its marketing -- on a website, in a brochure, in a sales presentation, on social media -- that testimonial becomes part of the company's promotional labeling. This means it must comply with all applicable regulations, including:
- Claims must be within the device's cleared or approved indications for use
- Claims must be truthful and not misleading
- Fair balance must be maintained -- risk information must accompany benefit claims
- Claims must be substantiated by competent and reliable evidence
The fact that the claims are in someone else's words does not absolve the company of responsibility. If you put a surgeon's quote in your brochure that says "This device has eliminated complications in my practice," that is your claim now. And you need evidence to support it.
The "Net Impression" Standard
The FDA evaluates testimonials based on the net impression they create -- the overall takeaway a reasonable reader would have. This means that even if a testimonial does not explicitly make an unapproved claim, the FDA will look at whether the testimonial, in context, implies claims that are not substantiated or outside your indications.
For example, a surgeon saying "I have started using this device for procedures I never thought possible" might not explicitly claim off-label use, but the net impression is that the device is being used beyond its intended purpose. That is a compliance problem.
Patient Testimonials: Unique Challenges
Patient testimonials present unique regulatory challenges that are distinct from healthcare professional endorsements.
Typicality and Representativeness
The FTC requires that endorsements reflect the honest opinions of the endorser and that results described are typical of what consumers can expect. For medical devices, this means patient testimonials should represent typical patient outcomes, not exceptional cases. If you feature a patient who had an extraordinary result that is not representative of the general patient population, you may need to include a disclaimer about typical results.
The challenge is that the patients most willing to give testimonials are often the ones who had the best outcomes. Nobody volunteers to star in a marketing video about their mediocre result. This creates a natural selection bias that companies must actively manage.
Privacy and HIPAA Considerations
Using patient testimonials requires proper authorization under HIPAA. Patients must provide written consent for the use of their health information in marketing, and they must understand how their testimonial will be used. Best practice is to have patients sign a specific marketing authorization form -- separate from their general HIPAA authorization -- that clearly describes the scope and duration of use.
Informed Consent for Marketing
Patients must understand what they are consenting to. This includes:
- How and where the testimonial will be used (website, social media, print, video)
- Whether they will be identified by name, image, or both
- How long the testimonial will be used
- Whether the testimonial can be edited (and if so, that edits will not change the meaning)
- Their right to withdraw consent
I recommend that device companies use a detailed marketing release form that covers all of these elements. A vague consent form is a liability waiting to happen.
Surgeon and KOL Testimonials
Healthcare professional testimonials -- particularly from key opinion leaders (KOLs) -- are the gold standard of medical device marketing endorsements. But they come with their own compliance requirements.
Financial Disclosures
The FTC requires disclosure of material connections between endorsers and companies. If the surgeon providing a testimonial has any financial relationship with your company -- consulting fees, speaking honoraria, research funding, equity, or any other compensation -- that relationship must be disclosed in connection with the testimonial.
The Physician Payments Sunshine Act (Open Payments) adds transparency requirements. All payments and transfers of value to physicians and teaching hospitals are publicly reported. Using a KOL's testimonial without disclosing the financial relationship, when that relationship is publicly available on Open Payments, is both a compliance violation and a credibility problem.
What Surgeons Can and Cannot Say
Even when using a real surgeon's real experience, the testimonial must stay within bounds:
- Within indications: The surgeon's experience must relate to an indicated use of the device
- Substantiated: Outcome claims must be supported by evidence, not just the surgeon's individual experience
- Not misleading: The testimonial must not create a false impression about the device's capabilities
- Fair balance: If the testimonial makes benefit claims, appropriate risk information must be provided
A common mistake is letting surgeons describe outcomes in ways that go beyond what the clinical evidence supports. A surgeon might say "I have seen a 90% reduction in complications" based on their personal experience, but if the published data shows a 30% reduction, using that testimonial is misleading.
Solicited vs. Unsolicited Testimonials
The distinction between solicited and unsolicited testimonials has important implications for how the FDA and FTC evaluate your compliance.
Solicited Testimonials
When your company actively requests testimonials -- through a formal KOL program, a patient ambassador program, a request for case studies, or even a casual email asking "Would you be willing to share your experience?" -- the resulting testimonials are considered solicited. The company has more control and therefore more responsibility.
Solicited testimonials should be:
- Reviewed by your regulatory team before use
- Accompanied by appropriate disclosures
- Consistent with your approved claims and indications
- Documented with signed agreements covering scope, duration, compensation, and compliance requirements
Unsolicited Testimonials
Unsolicited testimonials -- a surgeon who spontaneously posts about your device on social media, a patient who writes an unprompted review, a conference attendee who shares their experience on LinkedIn -- are generally not attributed to the company unless the company adopts them.
The moment you share, repost, feature, or reference an unsolicited testimonial in your marketing, you have adopted it. And once adopted, it is subject to the same compliance requirements as solicited testimonials.
FTC Endorsement Guidelines for Medical Devices
The FTC's Guides Concerning Use of Endorsements and Testimonials in Advertising (16 CFR Part 255) apply to medical device testimonials in addition to FDA regulations. Key FTC requirements include:
Truthfulness
Endorsements must reflect the honest opinions, findings, beliefs, or experience of the endorser. The endorser must have actually used the product and their statements must reflect their genuine experience. Scripting testimonials or putting words in an endorser's mouth violates this principle.
Material Connections
Any material connection between the endorser and the company must be clearly and prominently disclosed. Material connections include payment, free products, employment, consulting relationships, equity, and any other benefit the endorser receives. The disclosure must be in the testimonial itself or in immediate proximity -- not buried in a separate disclosure page.
Typical Results
The FTC has moved away from the "results not typical" disclaimer as a safe harbor. Under current guidelines, endorsements that describe results must either represent typical results or clearly disclose what consumers can generally expect. For medical devices, this means patient testimonials describing exceptional outcomes must include context about typical outcomes.
Expert Endorsements
When a healthcare professional endorses a medical device, the FTC considers this an expert endorsement. Expert endorsers must have qualifications sufficient to give them expertise in the area they are endorsing, must have actually examined the product or data, and their endorsement must be based on their expert evaluation -- not just on a paid relationship.
Building a Compliant Testimonial Program
Based on my experience working with dozens of device companies, here is the framework I recommend for building a testimonial program that is both effective and compliant:
Step 1: Define Your Testimonial Strategy
Before you start collecting testimonials, define what you want them to accomplish. Which marketing claims do you want to reinforce? Which audiences are you targeting? What channels will you use? This strategic foundation ensures that the testimonials you collect are useful and that they align with your approved messaging.
Step 2: Create Testimonial Guidelines
Develop clear guidelines for testimonial providers that explain what they can and cannot say. These guidelines should not script the testimonial -- that would undermine its authenticity and violate FTC principles -- but they should provide boundaries. For example: "Please share your honest experience with the device. Please do not discuss uses of the device that are not included in the approved indications for use."
Step 3: Implement Legal Agreements
Every testimonial provider should sign an agreement that covers:
- Scope of use (channels, duration, geography)
- Compensation (if any)
- Disclosure requirements
- Right to review and approve final content
- Compliance with regulatory requirements
- Representations that the testimonial reflects honest experience
- Right of the company to withdraw the testimonial if compliance issues arise
Step 4: Regulatory Review Before Use
Every testimonial -- every single one -- must go through regulatory review before it is used in any marketing context. This review should assess whether the testimonial stays within approved indications, whether claims are substantiated, whether fair balance requirements are met, and whether appropriate disclosures are included.
Step 5: Document Everything
Maintain a testimonial file that includes the signed agreement, the raw testimonial (video, audio, or text), any edits made and approval of those edits, the regulatory review and approval, financial disclosure documentation, and records of where and when the testimonial was used.
Step 6: Periodic Review
Review your active testimonials at least annually. Are they still current? Is the testimonial provider still associated with your device? Has the regulatory landscape changed? Have new clinical data or safety signals emerged that affect the credibility of the testimonial? Outdated testimonials are a compliance risk.
Common Testimonial Compliance Mistakes
Here are the most frequent mistakes I see medical device companies make with testimonials:
- Using testimonials that describe off-label use. A surgeon describes an innovative application of your device that is outside your cleared indications. It is a great story, and it is off-label promotion. Do not use it.
- Failing to disclose financial relationships. The surgeon giving a glowing testimonial is also a paid consultant. If the financial relationship is not disclosed, you have violated FTC guidelines and undermined your credibility with any audience that discovers the relationship independently.
- Editing testimonials to change their meaning. You can edit testimonials for length and clarity, but you cannot change what the person said. Editing a tepid endorsement into a ringing one is fabrication.
- Using patient testimonials without proper HIPAA authorization. A marketing release and a HIPAA authorization are not the same thing. You need both.
- Presenting atypical results as typical. Featuring only your best outcomes creates a misleading impression. The FTC expects endorsements to represent typical results or to disclose what typical results look like.
- No fair balance. A testimonial that describes only benefits without any reference to risks or limitations does not meet FDA fair balance requirements.
- Using outdated testimonials. A surgeon who endorsed your first-generation device five years ago may not endorse your current product. Using old testimonials for current products is misleading.
- Sharing unsolicited testimonials without review. A surgeon posts something great about your device. Your marketing team shares it immediately. But the post included an off-label claim that nobody caught. Now it is your compliance problem.
Video Testimonials: Special Considerations
Video testimonials are increasingly popular because they are more engaging and more persuasive than written testimonials. But they also create unique compliance challenges.
Key considerations for video testimonials:
- Script review vs. authenticity: You need to balance compliance with authenticity. Heavily scripted testimonials are less credible and may violate FTC principles. My approach is to provide guidelines, not scripts, and to review the footage before publication.
- Risk disclosures: Fair balance information should appear in the video itself -- either spoken or as on-screen text -- not just in the video description. If the video is shared on social media, the description may not travel with it.
- Surgical footage: If the testimonial includes surgical footage, ensure that the procedure shown is within your approved indications and that the footage does not show off-label use.
- Editing transparency: If you edit the video, maintain the original meaning. Do not cut statements in ways that change the endorser's message.
- Disclosure placement: Financial disclosures must be visible in the video, not just in the description. A text overlay or spoken disclosure at the beginning of the video is best practice.
Testimonials in Different Marketing Channels
The compliance requirements for testimonials apply across all channels, but the practical implementation varies:
Website
Testimonials on your website should include financial disclosures on the same page, links to full risk information, and clear identification of the endorser's qualifications. Testimonials should be current -- set an expiration date and review cycle.
Social Media
Character limitations make disclosure and fair balance challenging on social media. For platforms with space constraints, include a prominent link to full disclosures and risk information. For platforms that support longer content (LinkedIn, YouTube), include disclosures and fair balance directly in the post.
Print Materials
Print brochures and advertisements with testimonials must include financial disclosures, fair balance, and indication statements in the same piece. The FDA reviews print promotional materials through its APLB (Advertising and Promotional Labeling Branch), and testimonial compliance is a frequent area of scrutiny.
Sales Presentations
Testimonials used in sales presentations are subject to the same rules. If your sales team uses KOL video testimonials in their presentations, those videos must be approved, current, and accompanied by appropriate disclosures. The sales team should not use unapproved testimonials from their own interactions with surgeons.
Testimonials and the Sunshine Act
The Physician Payments Sunshine Act (Section 6002 of the ACA) requires manufacturers of drugs, devices, biologicals, and medical supplies to report payments and transfers of value to physicians and teaching hospitals. This reporting requirement has significant implications for testimonial programs.
If you pay a surgeon for a testimonial -- whether as a flat fee, an hourly rate, or as part of a broader consulting engagement -- that payment must be reported to CMS and will appear on the Open Payments database. Patients, journalists, and competitors can all access this information.
This transparency creates a powerful incentive for compliance. A surgeon testimonial accompanied by a clear financial disclosure is credible. The same testimonial without disclosure, discovered alongside a $50,000 consulting payment on Open Payments, becomes a scandal.
My advice: lean into transparency. Disclose financial relationships prominently and proactively. Healthcare professionals and patients respect honesty, and the alternative -- having the relationship exposed without your control -- is far worse.
International Testimonial Regulations
If your device is marketed internationally, be aware that testimonial regulations vary significantly by jurisdiction:
- European Union: The EU MDR (Medical Device Regulation 2017/745) restricts the use of patient testimonials in device marketing more strictly than the FDA does. Some EU member states prohibit patient testimonials for certain device categories entirely.
- United Kingdom: The MHRA and ASA (Advertising Standards Authority) have specific rules about testimonials in medical device advertising, including restrictions on implied claims and requirements for evidence substantiation.
- Australia: The TGA (Therapeutic Goods Administration) has strict rules about testimonials in advertising for therapeutic goods, including prohibitions on testimonials that describe personal experiences with the therapeutic effect of a device.
- Canada: Health Canada regulates medical device advertising and has specific requirements for endorsements and testimonials.
If you use the same testimonials across multiple markets, each market's regulatory requirements must be independently satisfied. A testimonial that is compliant in the US may not be compliant in the EU or Australia.
Building Trust Through Authentic Testimonials
I want to end with what I consider the most important insight from 18 years of working with medical device testimonials: the most effective testimonials are the most authentic ones, and authenticity and compliance are not in conflict.
The testimonials that drive the most sales are not the ones where a surgeon reads scripted superlatives. They are the ones where a thoughtful clinician describes, in their own words, how the device fits into their practice -- including its limitations. They are the ones where a patient shares their genuine experience, including the challenges of recovery. They are the ones that feel real because they are real.
Compliance requirements -- staying within indications, substantiating claims, providing fair balance, disclosing relationships -- all push testimonials toward authenticity. They prevent companies from cherry-picking the most extraordinary results, from hiding financial relationships, from presenting one-sided stories. And that is exactly what makes testimonials credible.
Build your testimonial program on a foundation of honesty, compliance, and authentic voices. It is the approach that works best for your regulatory standing and for your bottom line.
Case Study Testimonials: A Special Category
Case studies occupy a unique space in medical device testimonials because they combine a clinician's personal experience with clinical data -- and both elements are subject to regulatory scrutiny. A well-crafted case study can be one of the most persuasive marketing tools in your arsenal. A poorly constructed one can trigger FDA enforcement.
Here is how to build compliant case studies:
- Stay within indications. The case described must involve an indicated use of the device. Case studies describing off-label applications -- no matter how impressive the results -- are off-label promotion when used in marketing.
- Present representative outcomes. Do not cherry-pick your single best case. If you publish a case study showing dramatic results, the FTC expects that result to be representative or clearly identified as atypical. Including data about typical outcomes provides important context.
- Include complications and limitations. A case study that omits complications, unexpected findings, or limitations of the device creates a misleading impression. Fair balance applies to case studies just as it does to any other promotional material.
- Obtain proper consent. The patient described in the case study must provide informed consent for the marketing use of their clinical information. This consent must comply with HIPAA requirements and should include consent for publication in the specific channels you plan to use.
- Distinguish between promotional and scientific case studies. A case study published in a peer-reviewed journal as a scientific contribution is different from a case study used as a marketing tool. The former is generally considered scientific communication; the latter is promotional labeling. The distinction depends on context, sponsorship, and distribution.
The best case study testimonials I have seen are the ones that read like honest clinical reports rather than marketing pieces. They describe the clinical situation, the rationale for device selection, the procedure, the outcomes -- including any complications -- and the clinician's assessment. This format is both more credible and more compliant than a polished marketing narrative that presents only the positive aspects.
Managing Your Testimonial Library
As your testimonial program matures, you will accumulate a library of approved testimonials across multiple formats and channels. Managing this library effectively is a compliance requirement that many companies overlook.
Here is the management framework I recommend:
- Central repository. Maintain all approved testimonials in a single, centralized location. Each testimonial should be tagged with the product, the indication, the channel it is approved for, the date of approval, and the expiration date.
- Expiration dates. Set expiration dates for all testimonials. I recommend a maximum of two years from the date of approval, with annual review. Testimonials from providers who have changed their practice, moved to a competitor's device, or whose financial relationship has changed should be retired immediately.
- Usage tracking. Track where and when each testimonial is used across all marketing channels. This documentation is essential for audit readiness and helps you identify testimonials that may need updating or retirement.
- Version control. If a testimonial is edited for different channels (a full video for YouTube, a clip for Instagram, a quote for a brochure), each version must be separately approved and tracked. Ensure that edits do not change the meaning of the original testimonial.
- Regular audits. Review your entire testimonial library at least annually. Verify that all testimonials are current, that financial disclosures are accurate, that the supporting clinical evidence has not changed, and that the testimonials are still being used as approved. Retire any testimonials that no longer meet compliance standards.
A well-managed testimonial library is a competitive asset. It provides your marketing and sales teams with a ready supply of compliant, credible endorsements that can be deployed across channels with confidence. A poorly managed library is a regulatory liability that gets worse the longer it is neglected.